LRS Reports Unmatched Cooling Power in Stroke Patients - Results of SISCO Clinical Study Presented at 2024 ISC
On February 7, 2024, at this year's International Stroke Conference (ISC), Life Recovery Systems (LRS) presented the results of its IDE-approved SISCO Study, in which ischemic stroke patients were rapidly cooled with the ThermoSuit System (TSS). The TSS cooled patients to 34°C in a record time of 40 minutes in this pilot study. The authors of the study observed a 75% relative reduction in the rate of patients having mRS scores >3 at 90 days (patients unable to walk and talk) vs. retrospective controls. No previous stroke cooling studies have had such rapid cooling or any trend for outcome improvements in patients. The study also demonstrated the safety of the ThermoSuit treatment in stroke patients. A manuscript for publication is planned, as is a pivotal trial to seek FDA clearance for the indication. LRS thanks all who contributed to the SISCO study, including investors, contractors, and co-researchers, and the company is incredibly pleased to be positioned to help many thousands of patients in the future.
The ThermoSuit System uniquely uses liquid convection cooling to rapidly cool patients. Upon reaching target temperature the TSS is removed from the patient, and the patient can easily be maintained in the target range using standard cooling blankets or pads. The device is currently cleared under 510(k) by the U.S. Food and Drug Administration for patient temperature reduction where clinically indicated, e.g. for hyperthermic patients.
Matt Center, LRS CEO, notes, "This study demonstrates the unmatched cooling power and excellent safety of the ThermoSuit system, while showing a strong trend for improved outcomes. This greatly enhances the investment opportunity in LRS, and we are looking forward to continuing to aggressively pursue the FDA clearance for the stroke market."
About Life Recovery Systems
Founded in 2003, Life Recovery Systems focuses on innovative medical devices for the emergency medical care market. Its mission is to save and preserve the quality of patients' lives. LRS' first product, the TSS, was developed with funding assistance of NIH NHLBI to provide medical personnel with a safe, rapid method for cooling patients. LRS has offices in Alexandria, LA and Kinnelon, NJ, with the Sid Wolvek Research Center also based in NJ.
News published on and distributed by:
